Do omega-3, vitamin B12, vitamin D, and oxidative-inflammatory processes interact?

Omega-3 status, B12-dependent one-carbon metabolism, vitamin-D-related immune activity, and oxidative-inflammatory processes form a biologically credible network, but the full integrated interaction remains incompletely established in humans—particularly in an older adult.

Mechanistic and clinical evidence

• Omega-3 status has the clearest resolution pathway. EPA/DHA are precursors of specialized pro-resolving mediators (resolvins, protectins, maresins), which reduce neutrophil recruitment and inflammatory cytokine signaling, promote efferocytosis, and restore tissue homeostasis. In peripheral artery disease, fish oil increased the omega-3 index from 5±1% to 9±2%; doubling the index correlated with 1.7- to 3.6-fold higher SPM-pathway markers.
• B12 metabolism plausibly intersects with this network. Impaired methionine-synthase-dependent remethylation can raise homocysteine and reduce methyl-donor availability for S-adenosylmethionine-dependent DNA methylation, redox regulation, and immune-cell gene expression. Combined omega-3/B-vitamin treatment reduced homocysteine by about −1.37 µmol/L, but this does not prove direct modification of B12-dependent methylation by omega-3.
• Vitamin D has pro-resolving immune associations, yet direct evidence linking vitamin-D receptor signaling to SPM production or redox outcomes is not established.

Oxidative-inflammatory repair burden

• Persistent oxidative stress directly creates repair demand through oxidized DNA bases, strand breaks, lipid-peroxidation adducts, and activation of base-excision repair and ATM/ATR damage-response pathways. Inflammation can amplify this burden: activated immune cells and cytokines increase ROS/RNS, while oxidative nuclear or mitochondrial DNA injury can activate cGAS–STING, NF-κB, and NLRP3, reinforcing inflammation.
• This differs from transient, localized ROS signaling, which supports normal wound healing and host defense.

Neural implications

• Clinically overt B12 deficiency is the best-supported nutrient-related threat to neural maintenance; randomized evidence shows neurological improvement with replacement, including oral therapy. By contrast, 1 mg/day oral B12 for 12 months did not improve nerve conduction, neurological measures, or cognition in older adults with moderate/subclinical deficiency.

Bottom line

• The claim is directionally well grounded: sustained oxidative stress increases repair requirements, and overt B12 deficiency can impair neural maintenance. Omega-3 availability plausibly supports inflammatory resolution, but broad claims that marginal omega-3, vitamin D, or B12 abnormalities jointly drive clinical inflammation or neurological decline are not established.